Gene therapy moves forward in 2010

Molecular Therapy

Volumn 19, Issue 2, 2011, Pages 219-220

  Ylä Herttuala, Seppo ^a  

^a European Society of Gene and Cell Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; LENTIVIRUS VECTOR;

BETA THALASSEMIA; BURN; CELL THERAPY; CHRONIC GRANULOMATOUS DISEASE; EDITORIAL; ENZYME REPLACEMENT; EX VIVO GENE TRANSFER; GENE ACTIVATION; GENE INSERTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; GLOBOID CELL LEUKODYSTROPHY; HUMAN IMMUNODEFICIENCY VIRUS; HURLER SYNDROME; IMMUNE DEFICIENCY; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MURINE LEUKEMIA VIRUS; PLURIPOTENT STEM CELL; PUBLICATION; RNA INTERFERENCE; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; VIRAL GENE DELIVERY SYSTEM; WISKOTT ALDRICH SYNDROME;

CONGRESSES AS TOPIC; EUROPE; GENE THERAPY; HUMANS; SOCIETIES, MEDICAL;

EID: 79551618859     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.307     Document Type: Editorial

References (1)

1. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L et al. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360: 447-458.